MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

A significant milestone for both microbiome research and neurodegenerative diseases.

Core gut microbiota signature may serve as health indicator

The study identified a core microbiota signature that may serve as a health indicator and a therapeutic target.

Understanding the gut microbiota in athletes

Standardizing microbiome analysis improves the quality and reliability of data, helping researchers to explore the gut microbiota’s impact on athletes and its relationship with health and performance.

Microbial signatures for food traceability: ensuring quality and safety from fermented wines to novel insect-based foods

The interview with Antonia Bruno, from Bicocca University of Milan (Italy), highlights research focused on using microbial signatures to enhance food traceability, ensuring both safety and quality. 

Freya Biosciences secures $10.4 million investment to tackle women’s health challenges

A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.

From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy

Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…

Microbiota linked to susceptibility to necrotizing enterocolitis in preemies

The results also indicate that the hospital environment influences the gut bacteria of preterm infants, highligting the importance of managing antibiotics and medications to support a healthy gut development.

Microbiome’s implications in recurrent pregnancy loss

A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).

QIAGEN and McGill University partner to drive innovation in microbiome research

Three-year collaboration to pioneer new insights in microbial sciences and health applications.

Dietary fiber, bloutia, and mucus function: uncovering potential for Next-Generation Probiotics

The interview with Björn O. Schröder from Umeå University explores groundbreaking research on the gut mucus layer, which shields intestinal tissues from bacterial invasion and inflammation.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top